Medacta Group SA Concludes Successful Annual General Meeting

Medacta Group SA announced the outcomes of its 2026 Annual General Meeting held in Castel San Pietro, Switzerland. Shareholders approved all proposals by the Board of Directors. This included sanctioning a dividend distribution of approximately CHF 21.9 million, reflecting CHF 1.10 per share.

Additionally, Dr. Alberto Siccardi was re-elected as Chair of the Board alongside fellow board members. The Remuneration Committee welcomed back Philippe Weber and Riccardo Braglia for another term. The AGM saw representation of 17,656,822 shares, or 88.28% of Medacta's share capital.

Key reports such as the Management, Governance, and Sustainability Reports for 2025 were approved. Shareholders also discharged Board members and Executive Management from their duties, acknowledged compensation frameworks, and reaffirmed the roles of the independent proxy and auditors.